Introduction
The first choice for reconstruction of critical-size bone defects consists of autologous bone flaps, which often lack the required mechanical strength and cause significant donor-site morbidity. We have developed biological substitutes in a rabbit model by combining bone tissue engineering and flap pre-fabrication by wrapping the constructs in the highly vascularised panniculus carnosus muscle, in order to allow an ample vessel supply. This led to bone growth in the periphery, but necrosis in the core of the constructs (1). Here, we test the hypothesis that increased angiogenic stimulation from within the core of bone constructs by Vascular Endothelial Growth Factor (VEGF) can significantly accelerate early vascular in-growth and improve bone formation in the long term.
Materials and Methods
Bone marrow stromal cells (BMSC) from NZW rabbits were transduced with a retroviral vector to express rabbit VEGF linked to a truncated version of rabbit CD4 as a cell-surface marker. Cells were seeded in critical size (3x2 cm) HAscaffolds, which were wrapped in a panniculus carnosus flap and implanted ectopically. The kinetics of construct perfusion and tissue ingrowth was assessed by contrast-enhanced MRI 1, 4 and 8 weeks after implantation. Morphometric analysis of the induced bone tissue was performed by micro-CT on explanted constructs after 8 weeks. Bone formation and vascularisation were quantified histologically. Results BMSC were transduced with >80% efficiency 5-7 days after harvest. The transduced BMSC were purified by FACS based on their surface CD4 expression (2). Neither VEGF expression nor transduction impaired BMSC differentiation potential. In vivo experiments were performed on 6 rabbits, each carrying 3 critical-size scaffolds loaded with autologous BMSC (naïve, or transduced with either VEGF-expressing or control vectors). Angio-MRI signal-time curves showed higher contrast uptake in the constructs loaded with VEGF-expressing BMSC compared with control or naïve cells (Fig. 1) , indicating significantly improved construct perfusion already 1 week after implantation. Preliminary assessment by micro-CT indicates increased bone formation by VEGF-expressing BMSC after 8 weeks. Complete quantification of the angio-MRI and micro-CT results, as well as histological analysis of the explanted constructs are currently ongoing. 
